In addition, PANDA latent component 1 had high positive weights for PRAME and VIM, which are associated with progression of chronic myeloid leukemia (CML)24–26 and acute myeloid leukemia27,28, respectively. This evidence concerns the gene PANDAR and chronic myelogenous leukemia, BCR-ABL1 positive.